GVHD is primarily triggered when the donor's immune cells recognize the recipient's body as foreign. This immune reaction can be exacerbated by various factors, including genetic disparities between donor and recipient, or the presence of inflammatory cytokines. In the context of toxicology, the administration of certain immunosuppressive drugs to prevent GVHD can themselves have toxic effects on the body, complicating treatment.
